Clinical Trial Update: The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating zinc supplementation for left ventricular function in nonischemic cardiomyopathy has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Nonischemic Cardiomyopathy

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: University of Michigan | Conditions: Heart Failure, Cardiomyopathies | Phase 1 | Status: COMPLETED | Results posted: 2017-10-04